Literature DB >> 17917739

Clinical features of early and late stage polypoidal choroidal vasculopathy characterized by lesion size and disease duration.

Akiko Okubo1, Mayumi Hirakawa, Motoko Ito, Munefumi Sameshima, Taiji Sakamoto.   

Abstract

BACKGROUND: The pathogenesis of polypoidal choroidal vasculopathy (PCV), and even its clinical features, are controversial. Previous histopathological studies have identified different features; either dilated choroidal vessels or intra-Bruch's neovascularization. These differences might be partly attributable to the influence of the disease stage. We therefore evaluated the clinical features of early and late stage PCV.
METHODS: The medical records of 110 eyes of 97 PCV patients were retrospectively reviewed. The time between the subjective onset of visual abnormality and examination at our clinic and the greatest linear dimension of the total lesion at the first examination were investigated. The period of disturbed vision and lesion size data were placed in ascending order to determine the first quartile point. Eyes with both values at or below the first quartile point were classified as 'small-short' (early stage). Eyes with both values equal to at least the third quartile point were classified as 'large-long' (late stage). Fundus photography, indocyanine green and fluorescein angiography, visual acuity, and clinical course were compared.
RESULTS: Twelve eyes from 12 patients were small-short cases (period of disturbed vision of 1 month or less, lesion size 2.0 disc diameters or less). Eleven eyes from ten patients were large-long cases (period of disturbed vision 36 months or more, lesion size at least 5.0 disc diameters). The large-long eyes were characterized by occult choroidal neovascular membrane or scar tissue secondary to exudative age-related macular degeneration. Noticeable in the small-short eyes were atrophic changes in the retinal pigment epithelium, choroidal vessel hyperpermeability and pulsation. The visual prognosis and clinical course were different between the groups.
CONCLUSIONS: The difference of clinical features between the groups might reflect different disease stages, although not all of the features observed in the small-short group appeared to represent the early stages of those recorded in the large-long group. Thus, the variation in histopathologic features among previous reports might be partly attributable to differences in disease stage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17917739     DOI: 10.1007/s00417-007-0680-8

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  21 in total

1.  Clinicopathologic reports, case reports, and small case series: clinicopathologic correlation of idiopathic polypoidal choroidal vasculopathy.

Authors:  Robert H Rosa; Janet L Davis; Charles W G Eifrig
Journal:  Arch Ophthalmol       Date:  2002-04

2.  Correlation between indocyanine green angiographic findings and histopathology of polypoidal choroidal vasculopathy.

Authors:  Masami Nakajima; Mitsuko Yuzawa; Hiroyuki Shimada; Ryusaburo Mori
Journal:  Jpn J Ophthalmol       Date:  2004 May-Jun       Impact factor: 2.447

3.  The origins of polypoidal choroidal vasculopathy.

Authors:  M Yuzawa; R Mori; A Kawamura
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

4.  Idiopathic polypoidal choroidal vasculopathy in Japanese patients.

Authors:  M Uyama; T Matsubara; I Fukushima; H Matsunaga; K Iwashita; Y Nagai; K Takahashi
Journal:  Arch Ophthalmol       Date:  1999-08

5.  Idiopathic polypoidal choroidal vasculopathy (IPCV).

Authors:  L A Yannuzzi; J Sorenson; R F Spaide; B Lipson
Journal:  Retina       Date:  1990       Impact factor: 4.256

6.  Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation.

Authors:  H Terasaki; Y Miyake; T Suzuki; M Nakamura; T Nagasaka
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

7.  An update on multiple recurrent serosanguineous retinal pigment epithelial detachments in black women.

Authors:  B T Perkovich; Z N Zakov; L A Berlin; D Weidenthal; L R Avins
Journal:  Retina       Date:  1990       Impact factor: 4.256

8.  Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study.

Authors:  A Okubo; M Sameshima; A Uemura; S Kanda; N Ohba
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

9.  Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy.

Authors:  R F Spaide; L A Yannuzzi; J S Slakter; J Sorenson; D A Orlach
Journal:  Retina       Date:  1995       Impact factor: 4.256

10.  Polypoidal choroidal vasculopathy in elderly Chinese patients.

Authors:  Feng Wen; Changzheng Chen; Dezheng Wu; Haitao Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-06-29       Impact factor: 3.117

View more
  9 in total

1.  Development of polypoidal lesions in age-related macular degeneration.

Authors:  A Tsujikawa; Y Ojima; K Yamashiro; S Ooto; H Tamura; I Nakata; N Yoshimura
Journal:  Eye (Lond)       Date:  2011-01-21       Impact factor: 3.775

2.  Giant non-pulsatile polypoidal choroidal vasculopathy.

Authors:  Elton Lik Tong Tay; Augustinus Laude
Journal:  Int J Ophthalmol       Date:  2016-12-18       Impact factor: 1.779

3.  Proteolytic Degradation and Inflammation Play Critical Roles in Polypoidal Choroidal Vasculopathy.

Authors:  Sandeep Kumar; Hiroyuki Nakashizuka; Alex Jones; Alyssia Lambert; Xuchen Zhao; Megan Shen; Mackenzie Parker; Shixian Wang; Zachary Berriochoa; Amrita Fnu; Stephanie VanBeuge; Patricia Chévez-Barrios; Mark Tso; Jon Rainier; Yingbin Fu
Journal:  Am J Pathol       Date:  2017-09-21       Impact factor: 4.307

4.  The natural history of polypoidal choroidal vasculopathy: a multi-center series of untreated Asian patients.

Authors:  Chui Ming Gemmy Cheung; Elizabeth Yang; Won Ki Lee; Gary K Y Lee; Ranjana Mathur; Jacob Cheng; Doric Wong; Tien Yin Wong; Timothy Y Y Lai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-01-27       Impact factor: 3.117

5.  Genetic pleiotropy of ERCC6 loss-of-function and deleterious missense variants links retinal dystrophy, arrhythmia, and immunodeficiency in diverse ancestries.

Authors:  Iain S Forrest; Kumardeep Chaudhary; Ha My T Vy; Shantanu Bafna; Soyeon Kim; Hong-Hee Won; Ruth J F Loos; Judy Cho; Louis R Pasquale; Girish N Nadkarni; Ghislain Rocheleau; Ron Do
Journal:  Hum Mutat       Date:  2021-05-31       Impact factor: 4.700

6.  EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy.

Authors:  Colin S Tan; Wei Kiong Ngo; Jian Ping Chen; Nikolle W Tan; Tock Han Lim
Journal:  Br J Ophthalmol       Date:  2015-03-10       Impact factor: 4.638

7.  Spectral-domain optical coherence tomography findings in polypoidal choroidal vasculopathy suggest a type 1 neovascular growth pattern.

Authors:  Saeed T Alshahrani; Hanan N Al Shamsi; Eman S Kahtani; Nicola G Ghazi
Journal:  Clin Ophthalmol       Date:  2014-09-01

8.  Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab.

Authors:  Shozo Sonoda; Taiji Sakamoto; Hiroki Otsuka; Narimasa Yoshinaga; Toshifumi Yamashita; Yuya Ki-I; Akiko Okubo; Takehiro Yamashita; Noboru Arimura
Journal:  BMC Ophthalmol       Date:  2013-08-20       Impact factor: 2.209

9.  Associations of complement factor B and complement component 2 genotypes with subtypes of polypoidal choroidal vasculopathy.

Authors:  Koji Tanaka; Tomohiro Nakayama; Ryusaburo Mori; Naoyuki Sato; Akiyuki Kawamura; Mitsuko Yuzawa
Journal:  BMC Ophthalmol       Date:  2014-06-25       Impact factor: 2.209

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.